In Situ Neutralization and Detoxification of LPS to Attenuate Hyperinflammation
Abstract Hyperinflammation elicited by lipopolysaccharide (LPS) that derives from multidrug‐resistant Gram‐negative pathogens, leads to a sharp increase in mortality globally. However, monotherapies aiming to neutralize LPS often fail to improve the prognosis. Here, an all‐in‐one drug delivery strat...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-09-01
|
Series: | Advanced Science |
Subjects: | |
Online Access: | https://doi.org/10.1002/advs.202302950 |
_version_ | 1797684931538714624 |
---|---|
author | Xiaoyu Li Shaoqi Qu Xiangbin Song Congming Wu Jianzhong Shen Kui Zhu |
author_facet | Xiaoyu Li Shaoqi Qu Xiangbin Song Congming Wu Jianzhong Shen Kui Zhu |
author_sort | Xiaoyu Li |
collection | DOAJ |
description | Abstract Hyperinflammation elicited by lipopolysaccharide (LPS) that derives from multidrug‐resistant Gram‐negative pathogens, leads to a sharp increase in mortality globally. However, monotherapies aiming to neutralize LPS often fail to improve the prognosis. Here, an all‐in‐one drug delivery strategy equipped with bactericidal activity, LPS neutralization, and detoxification is shown to recognize, kill pathogens, and attenuate hyperinflammation by abolishing the activation of LPS‐triggered acute inflammatory responses. First, bactericidal colistin results in rapid bacterial killing, and the released LPS is subsequently sequestered. The neutralized LPS is further cleared by acyloxyacyl hydrolase to remove secondary fatty chains and detoxify LPS in situ. Last, such a system shows high efficacy in two mouse infection models challenged with Pseudomonas aeruginosa. This approach integrates direct antibacterial activity with in situ LPS neutralizing and detoxifying properties, shedding light on the development of alternative interventions to treat sepsis‐associated infections. |
first_indexed | 2024-03-12T00:36:57Z |
format | Article |
id | doaj.art-28dabe9881e14835b19e582a1146617b |
institution | Directory Open Access Journal |
issn | 2198-3844 |
language | English |
last_indexed | 2024-03-12T00:36:57Z |
publishDate | 2023-09-01 |
publisher | Wiley |
record_format | Article |
series | Advanced Science |
spelling | doaj.art-28dabe9881e14835b19e582a1146617b2023-09-15T09:28:59ZengWileyAdvanced Science2198-38442023-09-011026n/an/a10.1002/advs.202302950In Situ Neutralization and Detoxification of LPS to Attenuate HyperinflammationXiaoyu Li0Shaoqi Qu1Xiangbin Song2Congming Wu3Jianzhong Shen4Kui Zhu5National Key Laboratory of Veterinary Public Health Security College of Veterinary Medicine China Agricultural University Beijing 100193 ChinaNational Key Laboratory of Veterinary Public Health Security College of Veterinary Medicine China Agricultural University Beijing 100193 ChinaNational Key Laboratory of Veterinary Public Health Security College of Veterinary Medicine China Agricultural University Beijing 100193 ChinaNational Key Laboratory of Veterinary Public Health Security College of Veterinary Medicine China Agricultural University Beijing 100193 ChinaNational Key Laboratory of Veterinary Public Health Security College of Veterinary Medicine China Agricultural University Beijing 100193 ChinaNational Key Laboratory of Veterinary Public Health Security College of Veterinary Medicine China Agricultural University Beijing 100193 ChinaAbstract Hyperinflammation elicited by lipopolysaccharide (LPS) that derives from multidrug‐resistant Gram‐negative pathogens, leads to a sharp increase in mortality globally. However, monotherapies aiming to neutralize LPS often fail to improve the prognosis. Here, an all‐in‐one drug delivery strategy equipped with bactericidal activity, LPS neutralization, and detoxification is shown to recognize, kill pathogens, and attenuate hyperinflammation by abolishing the activation of LPS‐triggered acute inflammatory responses. First, bactericidal colistin results in rapid bacterial killing, and the released LPS is subsequently sequestered. The neutralized LPS is further cleared by acyloxyacyl hydrolase to remove secondary fatty chains and detoxify LPS in situ. Last, such a system shows high efficacy in two mouse infection models challenged with Pseudomonas aeruginosa. This approach integrates direct antibacterial activity with in situ LPS neutralizing and detoxifying properties, shedding light on the development of alternative interventions to treat sepsis‐associated infections.https://doi.org/10.1002/advs.202302950acyloxyacyl hydrolaseantibioticdelivery systemslipopolysaccharide |
spellingShingle | Xiaoyu Li Shaoqi Qu Xiangbin Song Congming Wu Jianzhong Shen Kui Zhu In Situ Neutralization and Detoxification of LPS to Attenuate Hyperinflammation Advanced Science acyloxyacyl hydrolase antibiotic delivery systems lipopolysaccharide |
title | In Situ Neutralization and Detoxification of LPS to Attenuate Hyperinflammation |
title_full | In Situ Neutralization and Detoxification of LPS to Attenuate Hyperinflammation |
title_fullStr | In Situ Neutralization and Detoxification of LPS to Attenuate Hyperinflammation |
title_full_unstemmed | In Situ Neutralization and Detoxification of LPS to Attenuate Hyperinflammation |
title_short | In Situ Neutralization and Detoxification of LPS to Attenuate Hyperinflammation |
title_sort | in situ neutralization and detoxification of lps to attenuate hyperinflammation |
topic | acyloxyacyl hydrolase antibiotic delivery systems lipopolysaccharide |
url | https://doi.org/10.1002/advs.202302950 |
work_keys_str_mv | AT xiaoyuli insituneutralizationanddetoxificationoflpstoattenuatehyperinflammation AT shaoqiqu insituneutralizationanddetoxificationoflpstoattenuatehyperinflammation AT xiangbinsong insituneutralizationanddetoxificationoflpstoattenuatehyperinflammation AT congmingwu insituneutralizationanddetoxificationoflpstoattenuatehyperinflammation AT jianzhongshen insituneutralizationanddetoxificationoflpstoattenuatehyperinflammation AT kuizhu insituneutralizationanddetoxificationoflpstoattenuatehyperinflammation |